Trial intelligence / Profile preview

NAFT-500 in tinea cruris

NCT00750152Phase 3Completed

Sponsor
Merz
Start
Sep 2008
Primary completion
Aug 2009
Countries
2
01

Overview

A Phase 3 trial of naftifine in Tinea cruris (TC), sponsored by Merz. Started Sep 2008; status: completed.

02

Drugs

naftifine
03

Conditions

Tinea cruris (TC)

Beyond the preview

Go deeper on NCT00750152.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00750152.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call